40200_2016_251_MOESM9_ESM.tif (604.14 kB)

Additional file 9: Figure S6. of Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study

Download (604.14 kB)
figure
posted on 02.08.2016, 05:00 by Thomas Wilke, Sabrina Mueller, Antje Groth, Bjoern Berg, Niklas Hammar, Katherine Tsai, Andreas Fuchs, Stephanie Stephens, Ulf Maywald
Kaplan-Meier (KM) curves for crude all-cause death rates, macrovascular event rates and T2DM-related hospitalizations for patients with either MET+SU or MET+DPP-4 therapy. The figure shows KM curves representing the percentage of event-free patients (all-cause event as well as mortality, MACE and T2DM-related hospitalizations) for the two cohorts defined above. Observation started with the first observed prescription of the second combination agent. (TIF 604 kb)

Funding

AstraZeneca

History

Exports